SDGR logo

Schrödinger (SDGR) Company Overview

Profile

Full Name:

Schrödinger, Inc.

Sector:

Healthcare

Industry:

Health Information Services

Country:

United States

IPO:

February 6, 2020

Indexes:

Not included

Website:

http://www.schrodinger.com

Description:

Schrodinger, Inc. is an American biotechnology company specializing in software for the discovery and research of new drugs. Founded in 1990, the company is headquartered in New York. Schrodinger has developed a computational platform that can predict critical properties of molecules with a high degree of accuracy. This key capability allows drug development teams to design and selectively synthesize molecules with more optimal properties, reducing on average the time and costs required to identify a development candidate, and increasing the likelihood that a drug discovery program will enter clinical development.

Key Details

Price

$21.02

Market Cap

$1.54 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$207.54 M(-4.21% YoY)

Annual EPS

-$2.57(-575.93% YoY)

PE Ratio

-

Annual ROE

-38.58%

Annual Debt To Equity

0.00

Beta

1.98

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Piper Sandler
Overweight
Jan 24, 25 Keybanc
Overweight
Nov 13, 24 BMO Capital
Outperform
Oct 17, 24 BMO Capital
Outperform
Aug 21, 24 Morgan Stanley
Equal-Weight
Jul 11, 24 Keybanc
Overweight
Jul 2, 24 Leerink Partners
Outperform
May 2, 24 Craig-Hallum
Buy
May 2, 24 Citigroup
Buy
Mar 1, 24 Goldman Sachs
Neutral

Screeners with SDGR included

Growing Shares Outstanding
US stocks
Stocks with high beta
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies
Small cap stocks
Health Information Services industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$21.02
SDGR price is $21.02

Price All-time High

$113.09
SDGR price is currently -81.41% below its historical high of $113.09

Price Analysts Target

$31.00
SDGR price is currently -32.19% lower than the consensus analysts' forecast

Price Most Recent Change

-1.31%
SDGR price was down -1.31% on Mar 7, 2025

Price YTD Change

+10.57%
SDGR price is up +10.57% since January 1st

Price 3-Year Change

-31.51%
SDGR price is down -31.51% over the past 3 years

Market cap

Market Cap

$1.54 B
SDGR market capitalization is $1.54 billion

Market Cap 3-Year Change

-29.58%
SDGR market capitalization is down -29.58% over the past 3 years

Market Cap All-time High

$7.92 B
SDGR market capitalization is currently -80.61% below its historical high of $7.92 billion

Market Cap Sector Rank

79.34%
SDGR market capitalization is higher than 79.34% of companies in Healthcare sector

Technical

Beta

1.98
SDGR beta is 1.98

200-day SMA

$20.74
SDGR price is currently +1.35% above its 200-day simple moving average

14-day RSI

40.36
SDGR 14-day relative strength index is 40.36

30-day Relative Volume

0.81
SDGR 30-day relative volume is 0.81

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$207.54 M
SDGR annual revenue is $207.54 million

Annual Revenue Analysts Estimate

$252.87 M
SDGR annual revenue is currently -17.93% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-4.21%
SDGR annual revenue is down -4.21% year-on-year

Annual Revenue Sector Rank

64.55%
SDGR annual revenue is higher than 64.55% of companies in Healthcare sector

Profit

Annual Gross Profit

$132.08 M
SDGR annual gross profit is $132.08 million

Annual Gross Margin

63.64%
SDGR annual gross profit margin is 63.64%

Annual Operating Profit

-$209.30 M
SDGR annual operating income is -$209.30 million

Annual Operating Margin

-100.85%
SDGR annual operating profit margin is -100.85%

Annual Net Income

-$187.12 M
SDGR annual net profit is -$187.12 million

Annual Net Margin

-90.16%
SDGR annual net profit margin is -90.16%

EPS

Annual EPS

-$2.57
SDGR annual earnings per share is -$2.57

Annual EPS Analysts Estimate

-$2.50
SDGR annual earnings per share is currently +2.80% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-575.93%
SDGR annual earnings per share is down -575.93% year-on-year

Annual EPS Sector Rank

36.48%
SDGR annual earnings per share is higher than 36.48% of companies in Healthcare sector

ROA & ROE

Annual ROA

-23.01%
SDGR annual return on assets is -23.01%

Annual ROE

-38.58%
SDGR annual return on equity is -38.58%

EBIT & EBITDA

Annual EBIT

-$209.30 M
SDGR annual earnings before interest & taxes is -$209.30 million

Annual EBITDA

-$203.14 M
SDGR annual EBITDA is -$203.14 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SDGR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SDGR price to earnings ratio is unknown

PB Ratio

PB Ratio

3.64
SDGR price to book ratio is 3.64

PB Ratio Sector Rank

74.3%
SDGR price to book ratio is higher than 74.3% of companies in Healthcare sector

PS Ratio

PS Ratio

7.40
SDGR price to sales ratio is 7.40

PS Ratio Sector Rank

73.01%
SDGR price to sales ratio is higher than 73.01% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.51 B
SDGR enterprise value is $1.51 billion

Enterprise Value Sector Rank

77.76%
SDGR enterprise value is higher than 77.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.41
SDGR EV/EBITDA is -7.41

EV/EBITDA Sector Rank

16.99%
SDGR EV/EBITDA is higher than 16.99% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.31
SDGR annual current ratio is 3.31

Annual Quick Ratio

-
SDGR annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
SDGR annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
SDGR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
SDGR piotroski f-score is 3

Altman Z-Score

1.46
SDGR altman z-score is 1.46

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$823.23 M
SDGR annual total assets is $823.23 million

Annual Non Current Assets

$188.23 M
SDGR annual long term assets is $188.23 million

Annual Current Assets

$634.99 M
SDGR annual total current assets is $634.99 million

Annual Cash & Cash Equivalents

$147.33 M
SDGR annual cash & cash equivalents is $147.33 million

Equity

Annual Book Value

$421.44 M
SDGR annual book value is $421.44 million

Annual Working Capital

$443.25 M
SDGR annual working capital is $443.25 million

Liabilities

Annual Total Liabilities

$401.78 M
SDGR annual total liabilities is $401.78 million

Annual Total Long Term Liabilities

$210.03 M
SDGR annual total long term liabilities is $210.03 million

Annual Current Liabilities

$191.75 M
SDGR annual total current liabilities is $191.75 million

Annual Accounts Payable

$10.67 M
SDGR annual accounts payable is $10.67 million

Debt

Annual Total Debt

$117.83 M
SDGR annual total debt is $117.83 million

Annual Total Debt 1-Year Change

-7.86%
SDGR annual total debt is down -7.86% year-on-year

Annual Long Term Debt

$101.07 M
SDGR annual long term debt is $101.07 million

Annual Short Term Debt

$16.75 M
SDGR annual short term debt is $16.75 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$416.83 M
SDGR annual total expenses is $416.83 million

Annual Operating Expenses

$341.38 M
SDGR annual total operating expenses is $341.38 million

Annual Cost Of Goods Sold

$75.46 M
SDGR annual cost of goods sold is $75.46 million

Annual SGA

$139.59 M
SDGR annual SGA is $139.59 million

Annual D&A

$6.16 M
SDGR annual depreciation & amortization is $6.16 million

Annual Interest Expense

-
SDGR annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$157.37 M
SDGR annual cash flow from operations is -$157.37 million

Annual CFO 1-Year Change

-15.09%
SDGR annual cash flow from operations is down -15.09% year-on-year

Annual CFI

$148.84 M
SDGR annual cash flow from investing activities is $148.84 million

Annual CFI 1-Year Change

-22.9%
SDGR annual cash flow from investing activities is down -22.9% year-on-year

Annual CFF

$10.12 M
SDGR annual cash flow from financing activities is $10.12 million

Annual CFF 1-Year Change

+11.88%
SDGR annual cash flow from financing activities is up +11.88% year-on-year

Free CashFlow

Annual FCF

-$164.68 M
SDGR annual free cash flow is -$164.68 million

Annual FCF 1-Year Change

-9.69%
SDGR annual free cash flow is down -9.69% year-on-year

CAPEX

Annual CAPEX

$7.31 M
SDGR annual capital expenditures is $7.31 million

Annual CAPEX 1-Year Change

-45.45%
SDGR annual capital expenditures is down -45.45% year-on-year

Institutional Ownership

Similar stocks

MNKD logo
MannKind (MNKD)
ATEC logo
Alphatec Holdings (ATEC)
WVE logo
Wave Life Sciences (WVE)
TVTX logo
Travere Therapeutics (TVTX)
TDOC logo
Teladoc Health (TDOC)
IMCR logo
Immunocore Holdings (IMCR)
BCRX logo
BioCryst Pharmaceuticals (BCRX)
KNSA logo
Kiniksa Pharmaceuticals (KNSA)
IDYA logo
IDEAYA Biosciences (IDYA)

FAQ

  • What is the ticker symbol for Schrödinger?
  • Does Schrödinger pay dividends?
  • What sector is Schrödinger in?
  • What industry is Schrödinger in?
  • What country is Schrödinger based in?
  • When did Schrödinger go public?
  • Is Schrödinger in the S&P 500?
  • Is Schrödinger in the NASDAQ 100?
  • Is Schrödinger in the Dow Jones?
  • When was Schrödinger's last earnings report?
  • When does Schrödinger report earnings?
  • Should I buy Schrödinger stock now?

What is the ticker symbol for Schrödinger?

The ticker symbol for Schrödinger is NASDAQ:SDGR

Does Schrödinger pay dividends?

No, Schrödinger does not pay dividends

What sector is Schrödinger in?

Schrödinger is in the Healthcare sector

What industry is Schrödinger in?

Schrödinger is in the Health Information Services industry

What country is Schrödinger based in?

Schrödinger is headquartered in United States

When did Schrödinger go public?

Schrödinger's initial public offering (IPO) was on February 6, 2020

Is Schrödinger in the S&P 500?

No, Schrödinger is not included in the S&P 500 index

Is Schrödinger in the NASDAQ 100?

No, Schrödinger is not included in the NASDAQ 100 index

Is Schrödinger in the Dow Jones?

No, Schrödinger is not included in the Dow Jones index

When was Schrödinger's last earnings report?

Schrödinger's most recent earnings report was on Feb 26, 2025

When does Schrödinger report earnings?

The next expected earnings date for Schrödinger is May 1, 2025

Should I buy Schrödinger stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions